These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 25112431)

  • 1. Reducing the risk of bias in health behaviour change trials: improving trial design, reporting or bias assessment criteria? A review and case study.
    de Bruin M; McCambridge J; Prins JM
    Psychol Health; 2015 Jan; 30(1):8-34. PubMed ID: 25112431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avoidable waste related to inadequate methods and incomplete reporting of interventions: a systematic review of randomized trials performed in Sub-Saharan Africa.
    Ndounga Diakou LA; Ntoumi F; Ravaud P; Boutron I
    Trials; 2017 Jul; 18(1):291. PubMed ID: 28676066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating complex interventions: perspectives and issues for health behaviour change interventions.
    Tarquinio C; Kivits J; Minary L; Coste J; Alla F
    Psychol Health; 2015 Jan; 30(1):35-51. PubMed ID: 25140439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using computer, mobile and wearable technology enhanced interventions to reduce sedentary behaviour: a systematic review and meta-analysis.
    Stephenson A; McDonough SM; Murphy MH; Nugent CD; Mair JL
    Int J Behav Nutr Phys Act; 2017 Aug; 14(1):105. PubMed ID: 28800736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of bias in randomized controlled trials published in prosthodontic journals.
    Dumbrigue HB; Jones JS; Esquivel JF
    J Prosthet Dent; 2001 Dec; 86(6):592-6. PubMed ID: 11753309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of registered and published intervention fidelity assessment in cluster randomised trials of public health interventions in low- and middle-income countries: systematic review protocol.
    Pérez MC; Minoyan N; Ridde V; Sylvestre MP; Johri M
    Syst Rev; 2016 Oct; 5(1):177. PubMed ID: 27756435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of comparisons of effect sizes derived from randomised and non-randomised studies.
    MacLehose RR; Reeves BC; Harvey IM; Sheldon TA; Russell IT; Black AM
    Health Technol Assess; 2000; 4(34):1-154. PubMed ID: 11134917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential attrition in health behaviour change trials: a systematic review and meta-analysis.
    Crutzen R; Viechtbauer W; Spigt M; Kotz D
    Psychol Health; 2015 Jan; 30(1):122-34. PubMed ID: 25109224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of bias in trial-based economic evaluations: identification of sources and bias-reducing strategies.
    Evers SM; Hiligsmann M; Adarkwah CC
    Psychol Health; 2015 Jan; 30(1):52-71. PubMed ID: 25141273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of bias in randomised controlled trials of health behaviour change interventions: evidence, practices and challenges.
    de Bruin M
    Psychol Health; 2015 Jan; 30(1):1-7. PubMed ID: 25223823
    [No Abstract]   [Full Text] [Related]  

  • 11. From question-behaviour effects in trials to the social psychology of research participation.
    McCambridge J
    Psychol Health; 2015 Jan; 30(1):72-84. PubMed ID: 25146179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized Controlled Trials 1: Design.
    Curtis BM; Barrett BJ; Parfrey PS
    Methods Mol Biol; 2021; 2249():193-211. PubMed ID: 33871845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adding quality to quantity in randomized controlled trials of addiction prevention and treatment: a new framework to facilitate the integration of qualitative research.
    Maher L; Neale J
    Addiction; 2019 Dec; 114(12):2257-2266. PubMed ID: 31400177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In randomization we trust? There are overlooked problems in experimenting with people in behavioral intervention trials.
    McCambridge J; Kypri K; Elbourne D
    J Clin Epidemiol; 2014 Mar; 67(3):247-53. PubMed ID: 24314401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key concepts in clinical epidemiology: addressing and reporting sources of bias in randomized controlled trials.
    Kotz D; West R
    J Clin Epidemiol; 2022 Mar; 143():197-201. PubMed ID: 34571193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk on bias assessment: (2) Revised Cochrane risk of bias tool for individually randomized, parallel group trials (RoB2.0)].
    Yang ZR; Sun F; Zhan SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Sep; 38(9):1285-1291. PubMed ID: 28910948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes to aspects of ongoing randomised controlled trials with fixed designs.
    Coskinas X; Simes J; Schou M; Martin AJ
    Trials; 2020 Jun; 21(1):457. PubMed ID: 32493444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Geriatric evaluation and management units: experimental methods for evaluating efficacy.
    Feussner JR
    J Am Geriatr Soc; 1991 Sep; 39(9 Pt 2):19S-24S. PubMed ID: 1885873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Layers of complexity in interpreting evidence on effectiveness.
    Tannahill A; Kelly MP
    Public Health; 2013 Feb; 127(2):164-70. PubMed ID: 23332513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials.
    Barker TH; Stone JC; Sears K; Klugar M; Tufanaru C; Leonardi-Bee J; Aromataris E; Munn Z
    JBI Evid Synth; 2023 Mar; 21(3):494-506. PubMed ID: 36727247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.